PROKIDNEY CORP.
PROKNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for PROK. That does not mean none is planned.
Get an email about PROK's next catalysts
Track PROKIDNEY (PROK) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
PROK Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.13 | FQ end Sep/2026 | Call: tbd
Market Overview
Stock performance and key metrics
Renal Autologous Cell Therapy (REACT/rilparencel)
Type 2 Diabetes Mellitus
Renal Autologous Cell Therapy (REACT)
Chronic Kidney Diseases
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Renal Autologous Cell Therapy (REACT/rilparencel) | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Renal Autologous Cell Therapy (REACT) | Phase 2 | Chronic Kidney Diseases | - | - |
Frequently asked questions
What is in PROKIDNEY CORP.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in PROKIDNEY CORP.'s (PROK) pipeline across Phase 3, Phase 2. Its lead program is Renal Autologous Cell Therapy (REACT/rilparencel) (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is PROKIDNEY CORP.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for PROKIDNEY CORP. (PROK) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track PROK biotech catalysts?→
Add PROK to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow PROKIDNEY CORP.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.